Lucid Diagnostics Inc. (LUCD)
1.56
-0.03 (-1.89%)
At close: Mar 28, 2025, 3:13 PM
Lucid Diagnostics Cash Flow Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Net Income | -45.53B | -52.67M | -56.17M | -28.08M | -8.28M | -4.42M | -1.13M |
| Depreciation & Amortization | 1.17B | 2.5M | 1.94M | 4K | n/a | n/a | n/a |
| Stock-Based Compensation | 4.53M | 6.82M | 14.99M | 9.6M | 65K | 173.94K | 79.85K |
| Other Working Capital | -4.53M | 5.61M | 9.17M | 1.67M | 1.44M | 1.58M | 222.83K |
| Other Non-Cash Items | 221.9M | 4.85M | 653K | 10.47M | -1.08M | -127.91K | -205.06K |
| Deferred Income Tax | n/a | n/a | n/a | -10.47M | n/a | n/a | n/a |
| Change in Working Capital | -4.43M | 5.67M | 8.91M | 807K | 2.59M | 1.89M | 720.05K |
| Operating Cash Flow | -44.14B | -32.82M | -29.68M | -17.67M | -5.63M | -2.36M | -113.7K |
| Capital Expenditures | n/a | -221K | -908K | -862K | n/a | n/a | n/a |
| Acquisitions | n/a | n/a | -3.2M | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | -646M | n/a | -3.2M | -862M | n/a | n/a | n/a |
| Investing Cash Flow | -646M | -221K | -4.11M | -862K | n/a | n/a | n/a |
| Debt Repayment | 18M | 10M | n/a | n/a | n/a | n/a | n/a |
| Common Stock Repurchased | 447M | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 48.23B | 19.18M | 804K | 2.08M | 5.58M | 2.5M | 131.5K |
| Financial Cash Flow | 48.25B | 29.46M | 2.61M | 72.08M | 5.58M | 2.5M | 131.5K |
| Net Cash Flow | 3.46B | -3.58M | -31.18M | 53.55M | -45.15K | 138.6K | 17.8K |
| Free Cash Flow | -44.14B | -33.04M | -30.59M | -18.53M | -5.63M | -2.36M | -113.7K |